MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 49 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3 | -99.4% | 6 | -99.4% | 0.00% | – |
| Q4 2022 | $466 | -53.4% | 931 | -43.7% | 0.00% | – |
| Q3 2022 | $1,000 | -66.7% | 1,655 | -54.5% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 3,638 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -98.0% | 3,638 | -97.5% | 0.00% | – |
| Q4 2021 | $148,000 | +7300.0% | 146,348 | +7927.9% | 0.00% | – |
| Q3 2021 | $2,000 | – | 1,823 | +2237.2% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 78 | -86.4% | 0.00% | – |
| Q1 2021 | $1,000 | -96.0% | 572 | -98.6% | 0.00% | – |
| Q1 2020 | $25,000 | -26.5% | 41,223 | +32.6% | 0.00% | – |
| Q1 2019 | $34,000 | +3300.0% | 31,089 | +3008.9% | 0.00% | – |
| Q3 2018 | $1,000 | -95.5% | 1,000 | -98.0% | 0.00% | – |
| Q2 2018 | $22,000 | +450.0% | 50,204 | +907.7% | 0.00% | – |
| Q1 2018 | $4,000 | -55.6% | 4,982 | -35.0% | 0.00% | – |
| Q4 2017 | $9,000 | +200.0% | 7,668 | +182.3% | 0.00% | – |
| Q3 2017 | $3,000 | – | 2,716 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 10,188,312 | $11,105,000 | 1.28% |
| Stonepine Capital Management, LLC | 2,008,006 | $2,189,000 | 1.26% |
| CVI Holdings, LLC | 909,625 | $991,000 | 0.94% |
| Vivo Capital, LLC | 6,818,181 | $7,432,000 | 0.74% |
| Broadfin Capital, LLC | 2,727,272 | $2,973,000 | 0.61% |
| Telemetry Investments, L.L.C. | 650,000 | $708,000 | 0.36% |
| Granite Point Capital Management, L.P. | 1,706,134 | $1,860,000 | 0.18% |
| J. Goldman & Co LP | 1,045,000 | $1,139,000 | 0.06% |
| Tibra Equities Europe Ltd | 241,966 | $264,000 | 0.03% |
| IPG Investment Advisors LLC | 42,500 | $46,325,000 | 0.02% |